A look at the new drugs transforming weight loss as we know it â from his personal experience on Ozempic to our ability to heal our society's dysfunctional relationship with food, weight, and our bodies.
What The Reviewers Say
Marion Winik,
The Washington Post
An easy-to-read summary of just what the subtitle suggests — benefits and risks — though there are a couple of points about which I think he’s wrong. And the amount of digressive fluff... implies this could have easily been a long magazine article rather than a short book.
Paul Nuki,
The Telegraph (UK)
Like so many who start to research our relationship with food for the first time, Hari is blown away by what he finds, and honest enough to recount it unadorned.
Matthew Rees,
The Wall Street Journal
[Hari] skillfully explores the effectiveness and the risks of Ozempic—as well as Wegovy and Mounjaro—and vividly depicts the food environment that has created a need for them.
Tom Whipple,
The Times (UK)
Sometimes Hari is still a little free and easy. Not only with irrebuttable speculations about future, as yet unknown side-effects, but also with his citations.